Literature DB >> 25307412

Establishment and characterization of metastatic gastric cancer cell lines from murine gastric adenocarcinoma lacking Smad4, p53, and E-cadherin.

Jun Won Park1,2, Dong Min Park1, Beom K Choi1, Byoung S Kwon1, Je Kyung Seong2, Jeffrey E Green3, Dae-Yong Kim2, Hark Kyun Kim1.   

Abstract

There is a strong need for murine gastric cancer cell line models recapitulating human gastric cancers. Here, we describe two murine gastric cancer cell lines designated as NCC-S1 and NCC-S3. They were generated from gastric adenocarcinomas that formed in a Villin-cre, Smad4(F/F) , Trp53(F/F) , Cdh1(F/wt) mouse and a Pdx1-cre, Trp53(F/F) , Cdh1(F/F) mouse, respectively. Molecular profiles of both cell lines were very similar to human gastric cancer. NCC-S1M and NCC-S3M subpopulation clones were isolated from pulmonary metastasis of heterotopic allografts of NCC-S1 and NCC-S3 cells, respectively. NCC-S1M and NCC-S3M showed enhanced in vivo growth rates and metastatic potentials and exhibited epithelial-to-mesenchymal transition features. NCC-S1M cells developed orthotopic and heterotopic tumors in immunocompetent mice in predictable manner, and were useful for testing the efficacy of an immunotherapeutic agent, anti-4-1BB antibody. NCC-S1M and NCC-S3M cells demonstrated Wnt/β-catenin pathway activation, and knockdown of Ctnnb1 reversed the metastatic phenotype of NCC-S1M. These results underscore the role of Wnt/β-catenin pathway in metastatic phenotype of gastric cancer. Taken together, our novel metastatic gastric cancer cell lines are useful resources for drug development and metastasis research.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  EMT; cell line; gastric cancer; mouse; β-catenin pathway

Mesh:

Substances:

Year:  2014        PMID: 25307412     DOI: 10.1002/mc.22226

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  11 in total

1.  Osteopontin depletion decreases inflammation and gastric epithelial proliferation during Helicobacter pylori infection in mice.

Authors:  Jun Won Park; Su Hyung Lee; Du Min Go; Hark Kyun Kim; Hyo-Jung Kwon; Dae-Yong Kim
Journal:  Lab Invest       Date:  2015-04-13       Impact factor: 5.662

Review 2.  Transgenic and gene knockout mice in gastric cancer research.

Authors:  Yannan Jiang; Yingyan Yu
Journal:  Oncotarget       Date:  2017-01-10

Review 3.  Molecular pathogenesis and emerging targets of gastric adenocarcinoma.

Authors:  Abby Ivey; Hillary Pratt; Brian A Boone
Journal:  J Surg Oncol       Date:  2022-06       Impact factor: 2.885

4.  Correlation analysis between the parameters of contrast-enhanced ultrasonography in evaluating cervical cancer metastasis and expression of E-cadherin.

Authors:  Xiaolan Lv; Min Hou; Xiaojing Duan
Journal:  Oncol Lett       Date:  2017-08-22       Impact factor: 2.967

5.  Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.

Authors:  Ting Li; Xujie Gao; Lei Han; Jinpu Yu; Hui Li
Journal:  World J Surg Oncol       Date:  2018-06-19       Impact factor: 2.754

6.  A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.

Authors:  Omkara Lakshmi Veeranki; Zhimin Tong; Alicia Mejia; Anuj Verma; Riham Katkhuda; Roland Bassett; Tae-Beom Kim; Jing Wang; Wenhua Lang; Barbara Mino; Luisa Solis; Charles Kingsley; William Norton; Ramesh Tailor; Ji Yuan Wu; Sunil Krishnan; Steven H Lin; Mariela Blum; Wayne Hofstetter; Jaffer Ajani; Scott Kopetz; Dipen Maru
Journal:  Dis Model Mech       Date:  2019-12-17       Impact factor: 5.758

7.  The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer.

Authors:  Chu-Feng Wang; Sheng-Jia Peng; Rong-Qiang Liu; Ya-Jie Yu; Qian-Min Ge; Rong-Bin Liang; Qiu-Yu Li; Biao Li; Yi Shao
Journal:  Dis Markers       Date:  2020-12-09       Impact factor: 3.434

8.  Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer.

Authors:  Jill P Smith; Hong Cao; Wenqiang Chen; Kanwal Mahmood; Teresa Phillips; Lynda Sutton; Allen Cato
Journal:  Front Oncol       Date:  2021-12-01       Impact factor: 6.244

9.  RhoGAP domain-containing fusions and PPAPDC1A fusions are recurrent and prognostic in diffuse gastric cancer.

Authors:  Hanna Yang; Dongwan Hong; Soo Young Cho; Young Soo Park; Woo Ri Ko; Ju Hee Kim; Hoon Hur; Jongkeun Lee; Su-Jin Kim; Sun Young Kwon; Jae-Hyuk Lee; Do Youn Park; Kyu Sang Song; Heekyung Chang; Min-Hee Ryu; Kye Soo Cho; Jeong Won Kang; Myeong-Cherl Kook; Nina Thiessen; An He; Andy Mungall; Sang-Uk Han; Hark Kyun Kim
Journal:  Nat Commun       Date:  2018-10-25       Impact factor: 14.919

10.  Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.

Authors:  Soo Young Cho; Jun Won Park; Yang Liu; Young Soo Park; Ju Hee Kim; Hanna Yang; Hyejin Um; Woo Ri Ko; Byung Il Lee; Sun Young Kwon; Seung Wan Ryu; Chae Hwa Kwon; Do Youn Park; Jae-Hyuk Lee; Sang Il Lee; Kyu Sang Song; Hoon Hur; Sang-Uk Han; Heekyung Chang; Su-Jin Kim; Byung-Sik Kim; Jeong-Hwan Yook; Moon-Won Yoo; Beom-Su Kim; In-Seob Lee; Myeong-Cherl Kook; Nina Thiessen; An He; Chip Stewart; Andrew Dunford; Jaegil Kim; Juliann Shih; Gordon Saksena; Andrew D Cherniack; Steven Schumacher; Amaro-Taylor Weiner; Mara Rosenberg; Gad Getz; Eun Gyeong Yang; Min-Hee Ryu; Adam J Bass; Hark Kyun Kim
Journal:  Gastroenterology       Date:  2017-05-15       Impact factor: 33.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.